Regarding the predictive value of brain age in the conversion from SCD/MCI to ADD, it is important to acknowledge its potential limitations compared to other techniques such as Aβ and tau protein assays in CSF and advanced neuroimaging methods like amyloid- and tau-PET. The gene discussed is MAPT; the disease is Schnyder corneal dystrophy.